Jiangsu Fuxin Huakang Packaging Material Co., Ltd. is a pharmaceutical packaging material enterprise integrating research and development, production, sales and import and export trade. The company's products cover three series of calendering, coating and compounding, including more than 30 varieties of PVC medicinal hard tablets, PVC/PVDC medicinal composite hard tablets and PVC/PE pharmaceutical composite hard tablets. The company started to produce pharmaceutical packaging materials as early as 1991, and has participated in the drafting of national standards, Relevant products have won the Domestic Research Progress Award, National New Product Award, China Light Industry Excellent Product Award, and Jiangsu Province Excellent New Product "Golden Bull Award".
In June 2021, the company was acquired by Dongfeng Co., Ltd. (stock code: 601515), and became the fourth holding subsidiary of Dongfeng Co., Ltd. of Class I drug packaging materials after Guizhou Chiba Pharmaceutical Packaging Co., Ltd., Chongqing Shoujian Pharmaceutical Packaging Materials Co., Ltd., Changzhou Huajian Pharmaceutical Packaging Materials Co., Ltd., with related products covering PVC hard sheets, PVC/PVDC composite hard sheets, PVC/PVDC/PE composite hard sheets, PVC/PE composite hard sheets, pharmaceutical packaging bottles, prickle aluminum caps Aluminum plastic composite cover, pharmaceutical SP composite film, pharmaceutical packaging aluminum foil, forming and stamping composite hard sheet (including cold stamping aluminum, tropical blister aluminum) and other pharmaceutical Class I packaging materials. The main business customers include Beijing Kexing Zhongwei, Tongjitang, Yiling Pharmaceutical, Sinopharm Group, Guangzhou Pharmaceutical Group, Taiji Group, Gooddoctor Pharmaceutical Group, Buchang Group, Suzhong Pharmaceutical, Sunflower Pharmaceutical, Yiyang Pharmaceutical, Hualan Biological Yangzijiang Pharmaceutical, Kunming Pharmaceutical Group, Beijing Tongrentang, China Resources Sanjiu, Amendment Pharmaceutical, Xiangxue Pharmaceutical, Jichuan Pharmaceutical, Huiren Pharmaceutical, Xinjiang Uygur Pharmaceutical, Huluwa Pharmaceutical, Guilin Sanjin Pharmaceutical, Kang'enbei, Guangxi Golden Throat, Shiyao Group Ouyi Pharmaceutical, Anbang Pharmaceutical, essence Pharmaceutical, Shandong Xinqi Pharmaceutical and other well-known pharmaceutical enterprises, and the annual sales revenue of the drug package sector will reach 540 million yuan in 2021.
The company has two production bases in Zhangqiao Town and Hongqiao Industrial Park in Taixing, Jiangsu Province, with a total investment of 200 million yuan. It has built a 7000m2 Class D purification workshop, including two PVC calendering production lines, two PVDC coating production lines and two composite production lines. The annual production capacity reaches 12000 tons of PVC hard sheets, 5000 tons of PVDC series composite hard sheets, and 4000 tons of PE series composite hard sheets.
The company adheres to the business philosophy of "taking product quality as the basis", has built professional laboratories, and products can be independently tested according to YBB standards. The main cooperative suppliers include Taiwan Formosa Plastics Group, Korea LG Group, Korea Hanhua Group, Japan Mitsui, Japan Zhongyuan, Germany BASF, Belgium Solvay, Japan Asahi and other well-known enterprises at home and abroad.
The company appreciates the trust and recognition of new and old customers, and will strive to provide customers with the best service and the most reliable products in the future, and will always remember the mission of "Well-being Pharmaceutical Enterprise, Healthy China"!